Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Paul Senior who wrote (17643)	11/19/2003 3:56:58 PM
From: Paul Senior	Read Replies (2) \| Respond to of 78752

Of the big three drug distributor type companies, CAH, ABC, and MCK, MCK seems to be having its stock move in opposite direction from the other two: finance.yahoo.com I'll diversify my position in the sector by buying an exploratory amount of MCK. Current p/e is under 14, with forward p/e now estimated (by Yahoo) about 11.4. In past, stock has often sold at higher p/sales than current .13. I look for the stock, now at $29 + -, to top $40 within two years. Not a particularly great percentage gain with that; otoh MCK's past good results and decent size and financials offer some suggestion of safety (maybe). Paul Senior